Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2009-08-29 01:25 | 2009-08-26 | NEP | NEPHROS INC | Southpaw Asset Management LP | 10% owner | SELL | $2.00 | 427,600 | $853,190 | 489,730 |
| 2009-08-28 18:33 | 2009-08-26 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | HENNEMAN JOHN B III | Officer | SELL | $34.83 | 5,500 | $191,547 | 88,941 |
| 2009-08-27 16:00 | 2009-08-26 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $41.57 | 100,000 | $4,156,910 | 17,186,682 |
| 2009-08-27 17:31 | 2009-08-26 | BDX | BECTON DICKINSON & CO | BECTON HENRY P JR | Director | SELL | $70.00 | 2,000 | $140,000 | 188,813 |
| 2009-08-27 18:55 | 2009-08-26 | ICUI | ICU MEDICAL INC/DE | COSTELLO RICHARD A | Officer | SELL | $38.00 | 468 | $17,784 | 0 |
| 2009-08-27 20:28 | 2009-08-26 | WST | WEST PHARMACEUTICAL SERVICES INC | McMillan Donald A | Officer | OPT+S | $40.37 | 4,000 | $161,465 | 10,944 |
| 2009-08-26 15:46 | 2009-08-25 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $41.45 | 30,000 | $1,243,518 | 17,286,682 |
| 2009-08-26 22:10 | 2009-08-20 | NEP | NEPHROS INC | Southpaw Asset Management LP | 10% owner | SELL | $2.55 | 30,000 | $76,524 | 73,068 |
| 2009-08-26 21:52 | 2009-08-24 | DCTH | DELCATH SYSTEMS, INC. | STOLL ROGER G PHD | Director | BUY | $3.06 | 10,000 | $30,590 | 10,000 |
| 2009-08-26 18:40 | 2009-08-25 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director, 10% owner | BUY | $0.44 | 35,100 | $15,444 | 3,755,100 |
| 2009-08-26 19:24 | 2009-08-26 | WST | WEST PHARMACEUTICAL SERVICES INC | HARGESHEIMER ROBERT S | Officer | SELL | $40.54 | 5,000 | $202,693 | 12,780 |
| 2009-08-26 18:45 | 2009-08-25 | WST | WEST PHARMACEUTICAL SERVICES INC | ABBOTT JOSEPH E | Officer | OPT+S | $40.80 | 6,000 | $244,794 | 16,932 |
| 2009-08-25 23:46 | 2009-08-21 | CRY | Artivion Inc. | Horton Amy | Officer | OPT+S | $8.15 | 2,000 | $16,300 | 26,232 |
| 2009-08-25 15:42 | 2009-08-24 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $41.73 | 10,000 | $417,301 | 17,316,682 |
| 2009-08-26 00:11 | 2009-08-24 | CRY | Artivion Inc. | LEE DAVID ASHLEY | Officer | OPT+S | $7.95 | 26,800 | $213,103 | 102,026 |
| 2009-08-25 18:35 | 2009-08-21 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director, 10% owner | BUY | $0.44 | 7,500 | $3,300 | 3,720,000 |
| 2009-08-25 17:38 | 2009-08-21 | WST | WEST PHARMACEUTICAL SERVICES INC | ELLERS STEVEN A | Officer | OPT+S | $40.65 | 10,000 | $406,493 | 115,210 |
| 2009-08-25 18:02 | 2009-08-21 | CRY | Artivion Inc. | McCall Ronald D | Director | SELL | $8.00 | 5,000 | $40,000 | 134,464 |
| 2009-08-24 23:07 | 2009-08-20 | BSX | BOSTON SCIENTIFIC CORP | Kucheman William | Officer | OPT+S | $11.20 | 11,668 | $130,682 | 29,385 |
| 2009-08-24 15:10 | 2009-08-21 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $41.73 | 100,000 | $4,173,080 | 17,326,682 |
| 2009-08-24 22:17 | 2009-08-21 | PDII | INTERPACE BIOSCIENCES, INC. | Smith Jeffrey Edward | Officer | BUY | $5.25 | 2,500 | $13,125 | 131,924 |
| 2009-08-21 15:29 | 2009-08-20 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $40.45 | 100,000 | $4,044,550 | 17,426,682 |
| 2009-08-21 19:49 | 2009-08-21 | BDX | BECTON DICKINSON & CO | BECTON HENRY P JR | Director | SELL | $67.65 | 200 | $13,530 | 109,483 |
| 2009-08-21 15:38 | 2009-08-20 | WST | WEST PHARMACEUTICAL SERVICES INC | MOREL DONALD E JR | Officer | SELL | $40.24 | 5,000 | $201,185 | 236,374 |
| 2009-08-20 15:17 | 2009-08-19 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $39.92 | 60,000 | $2,395,218 | 17,526,682 |
| 2009-08-20 22:29 | 2009-08-18 | RMD | RESMED INC | ROBERTS CHRISTOPHER G | Director | SELL | $44.96 | 20,000 | $899,180 | 178,700 |
| 2009-08-20 17:33 | 2009-08-19 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director, 10% owner | BUY | $0.45 | 11,300 | $5,085 | 3,712,500 |
| 2009-08-19 17:08 | 2009-08-18 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $39.69 | 100,000 | $3,968,770 | 17,586,682 |
| 2009-08-20 02:42 | 2009-08-18 | UTMD | UTAH MEDICAL PRODUCTS INC | HOYER ERNST G | Director | SELL | $28.65 | 3,995 | $114,457 | 43,844 |
| 2009-08-19 19:15 | 2009-08-18 | WST | WEST PHARMACEUTICAL SERVICES INC | GAILEY JOHN R | Officer | OPT+S | $39.21 | 28,800 | $1,129,133 | 20,362 |
| 2009-08-19 23:15 | 2009-08-18 | CRY | Artivion Inc. | RONALD C ELKINS | Director | SELL | $7.17 | 1,500 | $10,755 | 72,750 |
| 2009-08-18 16:32 | 2009-08-17 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $39.73 | 50,000 | $1,986,520 | 17,686,682 |
| 2009-08-19 02:19 | 2009-08-12 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $45.63 | 19,150 | $873,847 | 3,218 |
| 2009-08-18 22:13 | 2009-08-17 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director, 10% owner | BUY | $0.45 | 24,972 | $11,237 | 3,701,200 |
| 2009-08-19 02:56 | 2009-08-18 | ICUI | ICU MEDICAL INC/DE | CONNORS JOHN J | Director | SELL | $36.20 | 1,000 | $36,201 | 1,000 |
| 2009-08-18 23:00 | 2009-08-17 | WST | WEST PHARMACEUTICAL SERVICES INC | ANDERSON MICHAEL A | Officer | SELL | $38.66 | 4,500 | $173,970 | 36,095 |
| 2009-08-19 00:16 | 2009-08-17 | PDII | INTERPACE BIOSCIENCES, INC. | Lurker Nancy | Officer | BUY | $5.12 | 9,960 | $51,037 | 149,960 |
| 2009-08-17 20:39 | 2009-08-14 | ICUI | ICU MEDICAL INC/DE | Lamb Scott E | Officer | BUY | $28.53 | 136 | $3,880 | 1,093 |
| 2009-08-17 21:39 | 2009-08-13 | RMD | RESMED INC | Sandercock Brett | Officer | OPT+S | $45.50 | 5,000 | $227,500 | 14,435 |
| 2009-08-17 20:38 | 2009-08-14 | ICUI | ICU MEDICAL INC/DE | BRUMMETT BURCAR ALISON | Officer | BUY | $28.53 | 237 | $6,761 | 237 |
| 2009-08-17 20:39 | 2009-08-14 | ICUI | ICU MEDICAL INC/DE | RIGGS STEVEN | Officer | BUY | $28.53 | 234 | $6,675 | 1,252 |
| 2009-08-18 00:10 | 2009-08-13 | DXCM | DEXCOM INC | VALDES JORGE A | Officer | BUY | $6.90 | 5,000 | $34,480 | 25,289 |
| 2009-08-17 20:38 | 2009-08-14 | ICUI | ICU MEDICAL INC/DE | COSTELLO RICHARD A | Officer | BUY | $28.53 | 468 | $13,350 | 468 |
| 2009-08-14 23:43 | 2009-08-12 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $45.63 | 20,350 | $928,619 | 3,218 |
| 2009-08-14 23:43 | 2009-08-14 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director, 10% owner | BUY | $0.57 | 262,009 | $149,345 | 3,676,228 |
| 2009-08-14 23:18 | 2009-08-14 | GTF | Nuo Therapeutics, Inc. | Maslan Andrew Scott | Officer | BUY | $0.57 | 8,800 | $5,016 | 56,500 |
| 2009-08-14 23:14 | 2009-08-14 | GTF | Nuo Therapeutics, Inc. | ROSENDALE MARTIN P | Director, Officer | BUY | $0.57 | 17,500 | $9,975 | 68,534 |
| 2009-08-14 21:52 | 2009-08-13 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director, 10% owner | BUY | $0.45 | 6,885 | $3,098 | 3,414,219 |
| 2009-08-14 17:03 | 2009-08-12 | WST | WEST PHARMACEUTICAL SERVICES INC | ELLERS STEVEN A | Officer | OPT+S | $39.97 | 10,000 | $399,726 | 115,210 |
| 2009-08-14 23:22 | 2009-08-13 | CRY | Artivion Inc. | McCall Ronald D | Director | SELL | $6.12 | 7,662 | $46,898 | 139,464 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.